🇺🇸 FDA
Patent

US 8343737

Cell culture compositions capable of producing a VEGF-binding fusion polypeptide

granted A61KA61K38/00A61P

Quick answer

US patent 8343737 (Cell culture compositions capable of producing a VEGF-binding fusion polypeptide) held by REGENERON PHARMACEUTICALS, INC. expires Mon Dec 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Jan 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K38/00, A61P, A61P43/00